En Es
Categories

DIAZYME LABORATORIES

Diazyme develops diagnostic reagents using its proprietary enzyme technologies that can be used on most automated chemistry analyzers in user-friendly formats. Its product range includes test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes.
Products Covid-19Summary
Close

Covid-19 DIAZYME LABORATORIES

Clinical Laboratory

SARS-CoV2 Antibody Test
DZ-Lite SARS-CoV-2 IgG CLIA Kit

The Diazyme DZ-Lite SARS-CoV-2 IgG CLIA kit is for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma to aid identifying individuals with an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection. The test runs on the fully automated DZ-Lite 3000 Plus Chemiluminescence Analyzer and is an Emergency Use Authorization (EUA) test authorized by the US FDA for use by authorized laboratories.
More details

SARS-CoV2 Antibody Test
DZ-Lite SARS-CoV-2 IgM CLIA Kit

The Diazyme DZ-Lite SARS-CoV-2 IgM CLIA kit is for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma (potassium EDTA, disodium EDTA and lithium heparin) to aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. The test runs on the fully automated DZ-Lite 3000 Plus Chemiluminescence Analyzer and is an Emergency Use Authorization (EUA) test authorized by the US FDA for use by authorized laboratories.
More details

SARS-CoV-2 PCR Test
Macurra SARS-CoV-2 PCR Kit

The Macurra SARS-CoV-2 PCR Kit is a qualitative assay that allows the detection of nucleic acids in samples from patients who meet COVID-19 (coronavirus) clinical and/or epidemiological criteria. It is an Emergency Use Authorization (EUA) test authorized by the U.S. FDA for use by authorized laboratories.
More details
Close

About DIAZYME LABORATORIES

Diazyme develops diagnostic reagents using its proprietary enzyme technologies that can be used on most automated chemistry analyzers in user-friendly formats. Its product range includes test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes.
FaceBook Twitter Google+ Linked in
Glycated Serum Protein Assay

Glycated Serum Protein Assay

Model: GlycoGap
Request Information

Description:

The GlycoGap Glycated Serum Protein Assay in conjunction with Diazyme Glycated Serum Protein single calibrator is intended for the quantitative determination of glycated serum proteins (GSP; glycated albumins; fructosamine) in serum. The enzymatic assay for glycated serum protein provides improved specificity and reliability as compared to conventional NBT-based methods, and is highly precise with a total CV ≤ 1.
Read More

Full Description Features

Description

The GlycoGap Glycated Serum Protein Assay in conjunction with Diazyme Glycated Serum Protein single calibrator is intended for the quantitative determination of glycated serum proteins (GSP; glycated albumins; fructosamine) in serum. The enzymatic assay for glycated serum protein provides improved specificity and reliability as compared to conventional NBT-based methods, and is highly precise with a total CV ≤ 1.3%. Request Information

Features

Diazyme's enzymatic assay for glycated serum protein provides improved specificity and reliability compared to conventional NBT-based methods. The assay is highly precise with a total CV ≤ 1.3%. The assay offers extensive linearity up to 1354 μmol/L. The assay has no significant interference from: ascorbic acid (5 mg /dL); bilirubin (7.5 mg/dL); bilirubin conjugated (5 mg/dL); glucose (2400 mg/dL; hemoglobin (200 mg/dL); triglycerides (2000 mg/dL); and uric acid (35 mg/dL). Request Information

Send A Message To This Supplier

* Required Information
* Email
To
DIAZYME LABORATORIES (Glycated Serum Protein Assay)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions